Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Aranda

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Frontiers in Immunology|June 15, 2017
Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and ToleranceMarta Consuegra-Fernández, Mario Martínez-Florensa, Fernando Aranda, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial SepsisMario Martínez-Florensa, Marta Consuegra-Fernández, Fernando Aranda, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2017
Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis"Mario Martínez-Florensa, Marta Consuegra-Fernández, Fernando Aranda, et al.
Frontiers in Immunology|March 12, 2021
Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral ActivityMyriam Fernandez-Sendin, Claudia Augusta Di Trani, Angela Bella, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
International Journal of Cancer|June 17, 2009
Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapyDiana Llopiz, Javier Dotor, Noelia Casares, et al.
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Translational Lung Cancer Research|September 21, 2020
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancerAndrea Moreno-Manuel, Eloisa Jantus-Lewintre, Ines Simões, et al.
Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Oncoimmunology|August 2, 2014
Trial Watch: Toll-like receptor agonists in oncological indicationsFernando Aranda, Erika Vacchelli, Florine Obrist, et al.
Frontiers in Immunology|June 15, 2017
Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and ToleranceMarta Consuegra-Fernández, Mario Martínez-Florensa, Fernando Aranda, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2016
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial SepsisMario Martínez-Florensa, Marta Consuegra-Fernández, Fernando Aranda, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2017
Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis"Mario Martínez-Florensa, Marta Consuegra-Fernández, Fernando Aranda, et al.
Frontiers in Immunology|March 12, 2021
Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral ActivityMyriam Fernandez-Sendin, Claudia Augusta Di Trani, Angela Bella, et al.
Oncoimmunology|April 9, 2016
Trial Watch-Immunostimulation with cytokines in cancer therapyErika Vacchelli, Fernando Aranda, Norma Bloy, et al.
International Journal of Cancer|June 17, 2009
Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapyDiana Llopiz, Javier Dotor, Noelia Casares, et al.
Oncoimmunology|July 30, 2016
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapyAitziber Buqué, Norma Bloy, Fernando Aranda, et al.
Translational Lung Cancer Research|September 21, 2020
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancerAndrea Moreno-Manuel, Eloisa Jantus-Lewintre, Ines Simões, et al.
Oncoimmunology|November 18, 2017
Trial watch: Immune checkpoint blockers for cancer therapyClaire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, et al.
Pageof 11